0.14 EUR
1.57 M EUR
20.05 M EUR
2.14 M
About GENOWAY
Sector
Industry
CEO
Christian Grenier
Website
Headquarters
Lyon
Founded
1999
ISIN
FR0004053510
FIGI
BBG000R890N7
genOway SA engages in the development of genetically modified mouse, rat, and cellular models for biopharmaceutical and research companies. Its technologies include CRISPR/Cas9, homologous recombination (HR), site-specific recombination (SSR), internal ribosome entry sites (IRES), and tetracycline (TET). The company was founded by Alexandre Fraichard and Gilles de Poncins on March 1, 1999, and is headquartered in Lyon, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALGEN is 3.92 EUR — it has decreased by −0.25% in the past 24 hours. Watch GENOWAY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange GENOWAY stocks are traded under the ticker ALGEN.
ALGEN stock hasn't changed in a week, the month change is a 11.05% rise, over the last year GENOWAY has showed a −14.41% decrease.
We've gathered analysts' opinions on GENOWAY future price: according to them, ALGEN price has a max estimate of 6.60 EUR and a min estimate of 6.60 EUR. Watch ALGEN chart and read a more detailed GENOWAY stock forecast: see what analysts think of GENOWAY and suggest that you do with its stocks.
ALGEN reached its all-time high on May 29, 2007 with the price of 7.75 EUR, and its all-time low was 0.84 EUR and was reached on Feb 2, 2009. View more price dynamics on ALGEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALGEN stock is 0.51% volatile and has beta coefficient of 0.77. Track GENOWAY stock price on the chart and check out the list of the most volatile stocks — is GENOWAY there?
Today GENOWAY has the market capitalization of 35.17 M, it has increased by 1.79% over the last week.
Yes, you can track GENOWAY financials in yearly and quarterly reports right on TradingView.
ALGEN net income for the last half-year is 706.31 K EUR, while the previous report showed 549.69 K EUR of net income which accounts for 28.49% change. Track more GENOWAY financial stats to get the full picture.
No, ALGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 133.00 employees. See our rating of the largest employees — is GENOWAY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOWAY EBITDA is −1.28 M EUR, and current EBITDA margin is −4.80%. See more stats in GENOWAY financial statements.
Like other stocks, ALGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOWAY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOWAY technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOWAY stock shows the buy signal. See more of GENOWAY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.